Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia

被引:19
|
作者
Parajuli, Daya Ram [1 ,2 ,7 ]
Khanal, Saval [3 ]
Wechkunanukul, Kannikar Hannah [1 ,4 ]
Ghimire, Saurav [5 ]
Poudel, Arjun [6 ]
机构
[1] Torrens Univ Australia, Publ Hlth Dept, Adelaide, Australia
[2] Flinders Univ S Australia, Coll Med & Publ Hlth, Flinders Rural Hlth South Australia, Renmark, Australia
[3] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry, Warwickshire, England
[4] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Adelaide, Australia
[5] Univ Tasmania, Sch Med, Div Pharm, Hobart, Australia
[6] Queensland Univ Technol, Sch Clin Sci, Brisbane City, Qld, Australia
[7] Torrens Univ Australia, Publ Hlth Dept, 88 Wakefield St, Adelaide, SA 5000, Australia
来源
关键词
Pharmacy; Pharmacist; Australia; COVID-19; SHORTAGE; CRISIS;
D O I
10.1016/j.sapharm.2021.08.013
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The purpose of this paper is to provide an overview of the pharmacy practice and initiatives taken by the Australian federal government to ensure the continued supply of essential medicines under the conditions of an emergency response plan for COVID-19. During the pandemic, Australian pharmacists have been working collaboratively with multidisciplinary teams at the frontline to manage the equitable and safe supply of medicines despite the unprecedented situation. Although these presented problems for small pharmacies, social distancing policies were implemented widely to maintain personal and environmental hygiene and reduce the number of face-to-face patient visits. In collaboration with various pharmaceutical stakeholders, the Australian government responded rapidly to ensure equitable and sufficient supply with continued access to therapeutic goods during the pandemic. Additionally, vital policies and practices have been implemented, including supplying regular medicines at government-subsidized prices, a maximum one-month supply of some prescription medicines and purchase limits on over-the-counter medicines (one unit per purchase), medication management reviews through telehealth, electronic and digital prescribing, home delivery of medicines to vulnerable people and those in home isolation and the provision of serious shortage medicine substitution rights to pharmacists. Pharmacists were encouraged to communicate and collaborate with other local pharmacies to ensure that essential pharmacy services met community needs (e.g., opening hours). However, there has been a shortage of some medicines due to supply chain disruption and increased demand due to the pandemic. Higher demand for flu vaccinations, increased work pressure in pharmacies, and severe frustration and anxiety in pharmacy customers were also reported. Vigilance is required to monitor foreseeable shortages of therapeutics goods, particularly in regional pharmacies. There is an opportunity for long-term change to retain certain rights and roles based on the competence shown by pharmacists in this challenging period, such as telephone medication reviews, telehealth for MedsCheck and Diabetes MedsCheck, digital prescription handling and therapeutic substitution.
引用
收藏
页码:3453 / 3462
页数:10
相关论文
共 50 条
  • [1] Lessons from clinical practice during COVID-19 pandemic
    Kumar, Neeraj
    Kumar, Amarjeet
    Kumar, Abhyuday
    Kumar, Ajeet
    Sinha, Chandni
    [J]. TRENDS IN ANAESTHESIA AND CRITICAL CARE, 2020, 34 : 61 - 62
  • [2] The COVID-19 Pandemic in Australia: Lessons Learnt
    Berger, Emily
    Reupert, Andrea
    [J]. PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY, 2020, 12 (05) : 494 - 496
  • [3] Emergency preparedness and response (EP&R) by pharmacy professionals in India: Lessons from the COVID-19 pandemic and the way forward
    Meghana, Aruru
    Aparna, Yerramilli
    Chandra, Sekar M.
    Sanjeev, Sharma
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (01): : 2018 - 2022
  • [4] Health emergency preparedness and response to the COVID-19 pandemic: Lessons learnt from Mongolia
    Dagvadorj, Amarjargal
    Jantsansengee, Baigalmaa
    Balogun, Olukunmi O.
    Baasankhuu, Tovuusuren
    Lkhagvaa, Battur
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 21
  • [5] Pharmacy response to COVID-19: lessons learnt from Canada
    Ali Elbeddini
    Amy Botross
    Rachel Gerochi
    Mohamed Gazarin
    Ahmed Elshahawi
    [J]. Journal of Pharmaceutical Policy and Practice, 13
  • [6] Pharmacy response to COVID-19: lessons learnt from Canada
    Elbeddini, Ali
    Botross, Amy
    Gerochi, Rachel
    Gazarin, Mohamed
    Elshahawi, Ahmed
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2020, 13 (01)
  • [7] Pandemic Preparedness and Response: Lessons From COVID-19
    Fauci, Anthony S.
    Folkers, Gregory K.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (04): : 422 - 425
  • [8] The Federal Response to COVID-19: Lessons from the Pandemic
    Knauer, Nancy J.
    [J]. HASTINGS LAW JOURNAL, 2022, 73 (01) : 49 - 104
  • [9] Emergency remote teaching during COVID-19 pandemic: lessons learned from Cyprus
    Nisiforou, Efi A.
    Kosmas, Panagiotis
    Vrasidas, Charalambos
    [J]. EDUCATIONAL MEDIA INTERNATIONAL, 2021, 58 (02) : 215 - 221
  • [10] Who Australasians trusted during COVID-19: lessons from the pandemic response
    August, Raven
    Barrett-Young, Ashleigh
    Guiney, Hayley
    Hogan, Sean
    Ramrakha, Sandhya
    Poulton, Richie
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2023, 136 (1587) : 85 - 97